Silagra

Dosaggio del prodotto: 100mg
Confezione (n.)	Per compresse	Prezzo	Acquista
30	€1.85	€55.57 (0%)	🛒 Aggiungi al carrello
60	€1.30	€111.14 €77.80 (30%)	🛒 Aggiungi al carrello
90	€1.10	€166.71 €99.17 (41%)	🛒 Aggiungi al carrello
120	€1.00	€222.28 €120.54 (46%)	🛒 Aggiungi al carrello
180	€0.92	€333.41 €165.00 (51%)	🛒 Aggiungi al carrello
270	€0.85 Migliore per compresse	€500.12 €229.12 (54%)	🛒 Aggiungi al carrello

Prodotti simili

Product Description

Silagra is an oral pharmaceutical tablet indicated for the treatment of erectile dysfunction (ED) in adult men. Its active pharmaceutical ingredient is sildenafil citrate, a potent and selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). By enhancing the natural nitric oxide (NO)-cGMP pathway, Silagra facilitates the relaxation of smooth muscle in the corpus cavernosum of the penis, thereby promoting increased blood flow and enabling an erection in response to sexual stimulation. It is not an aphrodisiac and requires sexual arousal to be effective. This monograph provides a comprehensive, evidence-based review of Silagra for healthcare professionals and informed patients.

1. Introduction: What is Silagra? Its Role in Modern Medicine

Silagra is a medication belonging to the class of phosphodiesterase type 5 (PDE5) inhibitors. It is used for the treatment of erectile dysfunction, a prevalent condition affecting a significant percentage of the male population, with incidence increasing with age. Since the introduction of sildenafil citrate (originally under the brand name Viagra), the management of ED transformed from primarily psychological interventions and invasive procedures to effective, on-demand oral pharmacotherapy. Silagra, as a bioequivalent formulation containing sildenafil, represents a critical tool in urological and primary care practice, offering a reliable, non-invasive option to restore sexual function and, by extension, improve quality of life and psychological well-being for patients and their partners. Its role extends beyond mere symptom relief, often serving as a gateway for broader discussions about cardiovascular health, as ED can be an early marker of endothelial dysfunction.

2. Key Components and Bioavailability of Silagra

The core active component of Silagra is sildenafil citrate, chemically defined as 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate. Each tablet is standardized to contain either 25 mg, 50 mg, or 100 mg of sildenafil (calculated as the free base).

The formulation is designed for oral administration. Excipients typically include microcrystalline cellulose, calcium hydrogen phosphate, croscarmellose sodium, magnesium stearate, hypromellose, titanium dioxide, lactose, triacetin, and FD&C Blue #2 aluminum lake (in the 25 mg and 100 mg tablets).

Regarding bioavailability, sildenafil is rapidly absorbed after oral administration, with absolute bioavailability of approximately 40%. A high-fat meal can reduce the rate of absorption, lowering the peak plasma concentration (Cmax) by an average of 29% and delaying the time to peak concentration (Tmax) by approximately 60 minutes. For predictable and rapid onset, it is generally recommended to take Silagra on an empty stomach or after a light meal. The mean elimination half-life is about 3-5 hours, which informs its dosing schedule and duration of therapeutic effect.

3. Mechanism of Action of Silagra: Scientific Substantiation

The mechanism of action of Silagra is elegantly specific to the physiology of penile erection. During sexual stimulation, nitric oxide (NO) is released from nerve endings and endothelial cells in the corpus cavernosum. NO activates the enzyme guanylate cyclase, leading to increased levels of cyclic guanosine monophosphate (cGMP). cGMP acts as a second messenger, causing smooth muscle relaxation in the arteries and trabeculae of the corpus cavernosum. This vasodilation allows for a significant influx of blood, resulting in an erection.

The termination of this signal is primarily mediated by phosphodiesterase type 5 (PDE5), the enzyme responsible for breaking down cGMP. In men with ED, this NO-cGMP pathway is often impaired due to vascular, neurological, or psychological factors. Silagra (sildenafil) works by competitively and selectively inhibiting PDE5. By blocking this enzyme, sildenafil slows the degradation of cGMP, thereby amplifying and prolonging the natural erectile signal initiated by sexual arousal. It is crucial to understand that sildenafil has no effect in the absence of sexual stimulation, as it does not initiate the NO release; it merely potentiates the body’s own physiological response.

4. Indications for Use: What is Silagra Effective For?

The primary and approved indication for Silagra is the treatment of erectile dysfunction of organic, psychogenic, or mixed etiology. Its efficacy is well-established across a wide range of underlying conditions.

Silagra for Erectile Dysfunction of Vascular Origin

This is the most common scenario in clinical practice. ED is frequently a manifestation of endothelial dysfunction, sharing risk factors with cardiovascular disease (hypertension, dyslipidemia, diabetes, smoking). Silagra is highly effective in these cases by directly countering the impaired vasodilation in the penile arteries.

Silagra for ED Associated with Diabetes Mellitus

Diabetic neuropathy and microangiopathy are major contributors to ED. Studies consistently show that Silagra significantly improves erectile function in men with type 1 and type 2 diabetes, though response rates may be slightly lower than in non-diabetic populations, necessitating careful dose titration.

Silagra for Post-Prostatectomy ED

Following radical prostatectomy, especially non-nerve-sparing procedures, ED is common due to neuropraxia and vascular damage. Early use of PDE5 inhibitors like Silagra may aid in penile rehabilitation by promoting oxygenation of cavernosal tissues, potentially preventing fibrosis. It can be effective in a subset of these patients, particularly with nerve-sparing techniques.

Silagra for Psychogenic ED

While the primary dysfunction is psychological, the physical amplification of the arousal response provided by Silagra can help break the cycle of performance anxiety. A successful experience can restore confidence, making it a useful adjunct to psychosexual therapy.

5. Instructions for Use: Dosage and Course of Administration

Silagra is prescribed as an on-demand therapy. The recommended starting dose for most patients is 50 mg, taken approximately 30 minutes to 1 hour before anticipated sexual activity. The dose may be adjusted based on efficacy and tolerability to a maximum recommended dose of 100 mg or down to 25 mg.

Clinical Scenario	Recommended Dose	Timing	Administration Notes
Initial Therapy / General Use	50 mg	30-60 minutes before activity	Take on empty stomach for optimal speed of onset.
Insufficient Efficacy & Good Tolerability	100 mg	30-60 minutes before activity	Maximum recommended dose.
Elderly (>65), Hepatic Impairment, Severe Renal Impairment	25 mg	30-60 minutes before activity	Starting dose due to potential for increased exposure.
Concomitant Potent CYP3A4 Inhibitors (e.g., ritonavir, ketoconazole, erythromycin)	25 mg	30-60 minutes before activity	Maximum frequency: once every 48 hours.

The duration of the therapeutic window is typically up to 4-6 hours, though the ability to achieve an erection may persist longer. It should not be taken more than once per day. A course is not defined in the traditional sense; it is used per sexual encounter. However, some rehabilitation protocols for post-prostatectomy patients may involve regular low-dose or on-demand schedules.

6. Contraindications and Drug Interactions with Silagra

Absolute Contraindications:

Concomitant use of organic nitrates (e.g., nitroglycerin, isosorbide mononitrate/dinitrate) or nitric oxide donors in any form. This combination can cause a profound, life-threatening drop in blood pressure.
Hypersensitivity to sildenafil or any excipient.
Patients with severe cardiovascular disease for whom sexual activity is not advised (e.g., unstable angina, recent myocardial infarction, severe heart failure).
Concomitant use with guanylate cyclase stimulators (e.g., riociguat), due to the risk of hypotension.

Major Drug Interactions:

Nitrates: As above, absolutely contraindicated.
Alpha-blockers (e.g., doxazosin, tamsulosin): Concomitant use can lead to symptomatic postural hypotension. A starting dose of 25 mg Silagra is advised, and the patient should be stable on alpha-blocker therapy first.
Potent CYP3A4 Inhibitors: Drugs like ritonavir, ketoconazole, itraconazole, and clarithromycin significantly increase sildenafil plasma levels. Dose reduction to 25 mg and limiting frequency to once every 48 hours is mandatory.
Antihypertensics: Additive blood pressure-lowering effects are possible.

Important Safety Considerations:

Priapism: Prolonged erection >4 hours is a medical emergency requiring immediate intervention to prevent permanent tissue damage. Patients with conditions predisposing to priapism (sickle cell anemia, multiple myeloma, leukemia) should use with caution.
Cardiovascular Status: Sexual activity poses a cardiac risk. Physicians should assess cardiovascular fitness before prescribing.
Ocular Effects: Non-arteritic anterior ischemic optic neuropathy (NAION) has been reported rarely. Use with caution in patients with a history of NAION or significant optic nerve/cup disc ratio.
Hearing Loss: Sudden decrease or loss of hearing has been reported; a causal relationship is not definite but should be considered.
Pregnancy & Lactation: Silagra is not indicated for use in women.

7. Clinical Studies and Evidence Base for Silagra

The efficacy of sildenafil citrate, the active ingredient in Silagra, is supported by one of the most extensive bodies of clinical evidence in urological pharmacology. Pivotal randomized, double-blind, placebo-controlled trials formed the basis of its initial approval.

In a landmark 1998 study published in The New England Journal of Medicine, involving over 500 men with ED of various etiologies, 69% of sexual attempts were successful with sildenafil (100 mg dose) versus 22% with placebo. Patient diaries and validated questionnaires like the International Index of Erectile Function (IIEF) showed dramatic improvements in erectile function, penetration ability, and maintenance ability.

Subgroup analyses confirmed efficacy in challenging populations:

Diabetes: A 1999 study in Diabetes Care showed 56% of men with type 2 diabetes reported improved erections with sildenafil vs. 10% on placebo.
Spinal Cord Injury: Research in Annals of Neurology demonstrated significant improvement in men with ED due to spinal cord injury.
Depression: Studies controlling for antidepressant use (particularly SSRIs, which can cause ED) showed sildenafil was effective in improving erectile function in men with depressive disorders.

Long-term, open-label extension studies have demonstrated maintained efficacy and safety over several years of use. The consistency and robustness of this data across diverse patient groups underpin the authoritative position of sildenafil-based products like Silagra in treatment guidelines.

8. Comparing Silagra with Similar Products and Choosing a Quality Product

Silagra (sildenafil) is one of several PDE5 inhibitors. Key comparisons:

Vs. Tadalafil: Tadalafil has a significantly longer half-life (~17.5 hours), offering a longer window of effectiveness (up to 36 hours) and a licensed option for daily low-dose use. Silagra has a shorter, more defined window (4-6 hours), which some patients and partners prefer.
Vs. Vardenafil & Avanafil: These have similar half-lives to sildenafil. Subtle differences in selectivity and onset time exist but are often marginal in clinical practice. Individual patient response and side effect profiles can vary.

When choosing a sildenafil product, key considerations are:

Bioequivalence: Ensure the product is manufactured to GMP standards and is pharmaceutically equivalent to the reference product, guaranteeing consistent dose strength and absorption.
Source: Silagra or any PDE5 inhibitor should be obtained through a legitimate pharmacy with a valid prescription. Counterfeit products are prevalent online and pose serious health risks due to incorrect dosing, contamination, or lack of active ingredient.
Cost: As a generic formulation, Silagra is typically more cost-effective than brand-name counterparts while delivering the same therapeutic molecule.
Patient History: The choice between different PDE5 inhibitors should be individualized based on frequency of intercourse, desire for spontaneity vs. planning, side effect profile, concomitant medications, and cost.

9. Frequently Asked Questions (FAQ) about Silagra

What is the recommended course of Silagra to achieve results?

Silagra is not used in a traditional “course.” It is an on-demand medication taken approximately one hour before planned sexual activity. Its effect lasts for a single encounter within a window of several hours. Some rehabilitation protocols may use it regularly (e.g., 2-3 times per week) for a period.

Can Silagra be combined with alcohol?

Moderate alcohol consumption (1-2 drinks) is unlikely to affect efficacy significantly but may increase the risk of dizziness, orthostatic hypotension, and headache. Heavy alcohol use can impair erectile function itself and is not recommended.

Can Silagra be combined with blood pressure medication?

Yes, generally. However, as both can lower blood pressure, additive effects are possible. This is particularly important with alpha-blockers (see Section 6). Patients should be stable on their antihypertensive regimen before starting Silagra, and blood pressure should be monitored.

How quickly does Silagra start to work?

For most men, the onset of action is within 30-60 minutes when taken on an empty stomach. A high-fat meal can delay the onset.

What if a 50mg dose of Silagra doesn’t work?

Lack of effect at 50 mg may be due to insufficient dose, heavy food intake, lack of adequate sexual stimulation, or advanced neurovascular pathology. Under medical supervision, the dose can be increased to 100 mg. If still ineffective, alternative causes or treatments should be explored.

10. Conclusion: Validity of Silagra Use in Clinical Practice

In conclusion, Silagra (sildenafil citrate) remains a cornerstone in the evidence-based management of erectile dysfunction. Its well-elucidated mechanism of action, robust clinical trial data across diverse etiologies, and generally favorable safety profile when used appropriately, justify its first-line status. For the informed patient under proper medical supervision, Silagra offers a highly effective means of restoring sexual function, with the benefits often extending to improved self-esteem, relationship satisfaction, and overall quality of life. The key to its successful and safe use lies in a thorough medical evaluation to rule out contraindications, particularly cardiovascular instability and nitrate use, followed by patient education on proper dosing, timing, and realistic expectations.

Clinical Insights & Anecdotal Experience with Sildenafil

You know, when sildenafil first hit the scene, it was like someone turned on the lights in a room we’d been fumbling around in for decades. We went from awkward conversations about penile implants and painful injectables to, “Here, try this pill.” But the early days were messy. I remember the fierce debate in our urology department about whether we were just masking symptoms of heart disease. Old-school guys like Dr. Ahern were convinced we’d be triggering MIs left and right. Took a lot of grand rounds reviewing the hemodynamic data—the drop in BP is actually pretty mild for most—to calm those fears.

The real learning curve was in the nuances. The “take 50mg an hour before” on the label is a starting point, not a rule. I had a patient, Mark, a 58-year-old with well-controlled hypertension on amlodipine. 50mg did nothing for him. He was ready to give up. I asked about timing, and he said, “Oh, we usually have a big Saturday night dinner, then…” Bingo. We switched him to 100mg and had him take it before the meal, not after dessert. Night and day difference. It’s not always about upping the dose; sometimes it’s just pharmacokinetics.

Then there are the surprises. I treated a young guy, Liam, early 30s, with purely psychogenic ED after a bad relationship. Gave him a few 25mg samples just as a confidence booster. He came back a month later, not for a refill, but to say thanks. He said, “I used it twice, it worked, and then I realized I didn’t need it anymore. It just… rebooted the system.” That’s something you don’t see in the RCTs—the psychological cure facilitated by the drug.

We also see the failures, and you have to be honest about them. Post-radical prostatectomy cases, especially the non-nerve-sparing ones, are tough. I worked with a surgeon, brilliant but aggressive, who swore his technique spared everything. Patient, Robert, 65, came to me 6 months post-op with zero response to 100mg. I pushed for a penile Doppler. The results showed severe arterial insufficiency—the surgery had clearly damaged more than we hoped. We had to have a hard conversation about moving to second-line options. It taught me to never assume the etiology, even with a “clear” history.

The most important lesson, though, is in the follow-up. ED is a barometer. I had a 45-year-old, seemingly healthy, no prior diagnosis, who came in for ED. Started him on Silagra, it worked great. But I insisted on basic labs. His fasting glucose came back at 128 mg/dL. Prediabetes. The ED was the canary in the coal mine. Now we’re managing his metabolic health, and the Silagra is just one part of the picture. That’s the longitudinal view: it’s not just about prescribing a pill; it’s about listening to what the body is telling you through this very personal symptom. You get some guys who just want the script and to be left alone, but the ones who engage, who you follow over years—you see the real impact. It’s not just about sex; it’s about partnership, self-image, and sometimes, catching a serious health issue early. That’s the part of the job they don’t teach in the pharmacopeia.